MedShift Expands Portfolio to Include More Than a Dozen New Medical Devices
CHARLOTTE, N.C., Aug. 20, 2020 /PRNewswire-PRWeb/ -- Charlotte-based medical technology company, MedShift, recently announced the expansion of its current product portfolio, adding 14 new aesthetic medical devices to its lineup. The additions are expected to improve medical practices through expanding available treatment options to patients across plastic surgery, dermatology and other disciplines.
Because the global medical aesthetics market is expected to continue its expansion across the next few years, the addition of these new devices was a strong move for MedShift, who specializes in medical technology development and subscription-based device programs. Along with MedShift's highly valued technological innovations, MedShift IoT and MedBox, the company has found great success in the placement of previous devices, and anticipates the same outcome for the new product lineup.
The curated additions include various systems that offer laser hair removal, skin rejuvenation, fractional resurfacing, and tattoo removal. Of the 14 devices, the popular miraDry®, NeoGen(TM) PSR and Tetra CO2 devices are included in the lineup.
"We are pleased to offer our practices top of the line devices, including the new portfolio additions. Our goal is to successfully provide our valued customers with systems that are in high demand, and we believe that we can do so through increasing our selections and placement via our subscription-based services for a fraction of the cost," said Lisa Tiller, VP of Sales at MedShift.
With the new additions, MedShift now offers over 24 market leading devices in its portfolio, and has partnered with over 300 medical practices across North America. For more details on all MedShift device and technology offerings, visit http://www.medshift.com.
About MedShift
MedShift, founded in 2015 in Charlotte, NC delivers a platform as a service to both medical device manufacturers as well as individual medical practices. Foundationally MedShift enables access to the latest devices and technology to remain competitive and attract new business. MedShift has partnered with over 300 doctors in North America, Australia, and New Zealand to give practices the latest in cutting-edge treatment modalities, services, and systems.
MedShift is disrupting the traditional aesthetic device market by offering permanent placement, holistic subscription services for surgeons, physicians and their business. MedShift's broad portfolio of services for practices includes a portfolio of 24 leading aesthetic medical devices from nine manufacturers, an aesthetic eCommerce and subscription platform, in-house communications and marketing services, and inbound lead generation. For manufacturers Medshift delivers a highly secure IoT platform consisting of both hardware and software assets allowing for real time visibility, remote management, and big data modeling of entire medical device lineups. MedShift adds value across the manufacturer and provider spectrum and continues to empower robust integration with the leading brands and doctors in the industry. Additionally, in its first year of eligibility, MedShift ranked 185 on the 2020 Inc. 5000 list, leading as the 15th fastest growing health company in the United States.
SOURCE MedShift
